Just a thought, whether fully approved, or not, wouldn't it be possible for any new trials utilizing DCVax-L be done with the EDEN unit. If so, an additional question would be, are the EDEN units provided to the clinical sites which probably already have the other capabilities needed to utilize them, or will the trial vaccine all be made at some centralized sites.
Gary
Bullish
News 
Market Data 
Discover 
